GleamWall
中文EN

MHUAF Meihua International Medical Technologies Co., Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1835615 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-36.2%
TTM net income YoY-37.5%
TTM EPS YoY-54.5%
Revenue 3-yr CAGR-15.8%
Net income 3-yr CAGR2.8%

Margins

Gross margin31.0%
Operating margin13.4%
Net margin11.0%
FCF margin0.9%
EBITDA margin14.3%

Returns

ROE3.9%
ROA3.4%
ROIC (approx.)3.8%
Asset turnover0.31x

Leverage & solvency

Liabilities / assets8.8%
Debt / equity0.00x
Current ratio8.42x
Interest coverage34.30x

Cash quality & payout

Operating cash flow / net income0.08x
Accruals ratio3.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$61.79M$96.91M
Cost of revenue$42.63M$63.61M
Gross profit$19.16M$33.30M
R&D expense$2.38M$3.46M
SG&A expense$3.21M$7.78M
Operating income$8.28M$14.31M
Interest expense$241,523$1.51M
Pretax income$9.41M$13.63M
Income tax$2.62M$2.79M
Net income$6.78M$10.84M
EBITDA$8.82M$14.86M
EPS (basic)18.0439.62
EPS (diluted)18.0439.62
Weighted avg. shares (diluted)376,035273,717
Banking
Net interest income—-$1.51M
Balance sheet
Cash & equivalents$15.15M$17.29M
Receivables$84.33M$78.66M
Inventory$1.70M$1.41M
Current assets$153.58M$143.44M
PP&E, net$7.70M$7.89M
Goodwill—$7.90M
Intangibles$446,495$443,035
Total assets$207.18M$186.24M
Current liabilities$18.25M$27.26M
Short-term debt$8.99M$7.95M
Total liabilities$18.25M$27.26M
Shareholders' equity$188.93M$158.98M
Shares outstanding—31.90M
Cash flow statement
Operating cash flow$569,883$14.64M
Capital expenditure$15,629$133,550
Free cash flow$554,254$14.50M
Investing cash flow-$20.13M-$20.42M
Financing cash flow$17.19M$6.21M
Depreciation & amortization$533,963$543,658
Share buybacks—$200,000

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.